SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abraxis BioScience, Inc.: ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer